GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp2
|
ENSMUSG00000029563.17 | forkhead box P2 |
Foxp3
|
ENSMUSG00000039521.14 | forkhead box P3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp3 | mm39_v1_chrX_+_7446721_7446732 | -0.57 | 3.1e-04 | Click! |
Foxp2 | mm39_v1_chr6_+_14901439_14901531 | 0.15 | 4.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_130589321 | 5.68 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr1_-_130589349 | 5.61 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr11_+_69945157 | 5.53 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr6_+_121323577 | 4.89 |
ENSMUST00000032200.16
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr7_+_140343652 | 4.78 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr14_-_52150804 | 4.68 |
ENSMUST00000004673.15
ENSMUST00000111632.5 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr5_-_145816774 | 4.55 |
ENSMUST00000035918.8
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr19_+_30210320 | 4.42 |
ENSMUST00000025797.7
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr1_-_180023518 | 4.19 |
ENSMUST00000162769.8
ENSMUST00000161379.2 ENSMUST00000027766.13 ENSMUST00000161814.8 |
Coq8a
|
coenzyme Q8A |
chr1_-_180023467 | 4.13 |
ENSMUST00000161746.2
ENSMUST00000160879.7 |
Coq8a
|
coenzyme Q8A |
chr14_-_52151537 | 4.12 |
ENSMUST00000227402.2
ENSMUST00000227237.2 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr14_-_52151026 | 4.03 |
ENSMUST00000228164.2
|
Ndrg2
|
N-myc downstream regulated gene 2 |
chr10_+_93324624 | 3.98 |
ENSMUST00000129421.8
|
Hal
|
histidine ammonia lyase |
chr5_+_90708962 | 3.91 |
ENSMUST00000094615.8
ENSMUST00000200765.2 |
Albfm1
|
albumin superfamily member 1 |
chr2_-_134396268 | 3.88 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr15_-_78352801 | 3.60 |
ENSMUST00000229124.2
ENSMUST00000230226.2 ENSMUST00000017086.5 |
Tmprss6
|
transmembrane serine protease 6 |
chr14_+_55798362 | 3.57 |
ENSMUST00000072530.11
ENSMUST00000128490.9 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr17_-_12894716 | 3.55 |
ENSMUST00000024596.10
|
Slc22a1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr11_+_70104929 | 3.53 |
ENSMUST00000094055.10
ENSMUST00000126296.8 ENSMUST00000136328.2 ENSMUST00000153993.3 |
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr14_+_55797934 | 3.52 |
ENSMUST00000121622.8
ENSMUST00000143431.2 ENSMUST00000150481.8 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr9_+_46179899 | 3.43 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr11_+_69983459 | 3.21 |
ENSMUST00000102572.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr11_+_69983531 | 3.14 |
ENSMUST00000124721.2
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr11_+_69983479 | 3.09 |
ENSMUST00000143772.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr14_+_55798517 | 3.06 |
ENSMUST00000117701.8
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr6_+_116627567 | 3.04 |
ENSMUST00000067354.10
ENSMUST00000178241.4 |
Depp1
|
DEPP1 autophagy regulator |
chr11_+_78389913 | 2.94 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chr4_+_144619647 | 2.86 |
ENSMUST00000154208.8
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr2_+_58645189 | 2.82 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr15_+_99290832 | 2.79 |
ENSMUST00000160635.8
ENSMUST00000161250.8 ENSMUST00000229392.2 ENSMUST00000161778.8 |
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr4_+_144619696 | 2.76 |
ENSMUST00000142808.8
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr4_+_144619397 | 2.71 |
ENSMUST00000105744.8
ENSMUST00000171001.8 |
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr5_-_87716882 | 2.70 |
ENSMUST00000113314.3
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr11_+_108286114 | 2.67 |
ENSMUST00000000049.6
|
Apoh
|
apolipoprotein H |
chr4_+_138181616 | 2.67 |
ENSMUST00000050918.4
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr15_+_3300249 | 2.65 |
ENSMUST00000082424.12
ENSMUST00000159158.9 ENSMUST00000159216.10 ENSMUST00000160311.3 |
Selenop
|
selenoprotein P |
chr15_+_99291100 | 2.64 |
ENSMUST00000159209.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chrX_+_138701544 | 2.63 |
ENSMUST00000054889.4
|
Cldn2
|
claudin 2 |
chrX_+_100419965 | 2.60 |
ENSMUST00000119080.8
|
Gjb1
|
gap junction protein, beta 1 |
chr6_+_30541581 | 2.60 |
ENSMUST00000096066.5
|
Cpa2
|
carboxypeptidase A2, pancreatic |
chr6_+_116627635 | 2.55 |
ENSMUST00000204555.2
|
Depp1
|
DEPP1 autophagy regulator |
chr18_-_39051695 | 2.55 |
ENSMUST00000040647.11
|
Fgf1
|
fibroblast growth factor 1 |
chrX_-_7547273 | 2.51 |
ENSMUST00000115695.4
|
Magix
|
MAGI family member, X-linked |
chr8_-_122671588 | 2.49 |
ENSMUST00000057653.8
|
Car5a
|
carbonic anhydrase 5a, mitochondrial |
chr1_-_162726234 | 2.42 |
ENSMUST00000111510.8
ENSMUST00000045902.13 |
Fmo2
|
flavin containing monooxygenase 2 |
chr11_-_86884507 | 2.38 |
ENSMUST00000018571.5
|
Ypel2
|
yippee like 2 |
chr4_+_133280680 | 2.37 |
ENSMUST00000042706.3
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr2_+_58644922 | 2.32 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr1_+_130793406 | 2.31 |
ENSMUST00000038829.7
|
Fcmr
|
Fc fragment of IgM receptor |
chr10_+_87695352 | 2.30 |
ENSMUST00000121952.8
ENSMUST00000126490.8 |
Igf1
|
insulin-like growth factor 1 |
chr10_-_89369432 | 2.29 |
ENSMUST00000105297.2
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr11_+_70104736 | 2.29 |
ENSMUST00000171032.8
|
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr12_-_103871146 | 2.11 |
ENSMUST00000074051.6
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr12_-_81014849 | 2.09 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr12_-_84497718 | 2.07 |
ENSMUST00000085192.7
ENSMUST00000220491.2 |
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr1_+_171052623 | 2.04 |
ENSMUST00000111321.8
ENSMUST00000005824.12 ENSMUST00000111320.8 ENSMUST00000111319.2 |
Apoa2
|
apolipoprotein A-II |
chr2_-_110136074 | 2.02 |
ENSMUST00000046233.9
|
Bbox1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
chr12_-_81014755 | 1.99 |
ENSMUST00000218342.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr14_-_31362835 | 1.96 |
ENSMUST00000167066.8
ENSMUST00000127204.9 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr11_+_114741948 | 1.91 |
ENSMUST00000133245.2
ENSMUST00000122967.3 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr19_+_42078859 | 1.88 |
ENSMUST00000235932.2
ENSMUST00000066778.6 |
Pi4k2a
|
phosphatidylinositol 4-kinase type 2 alpha |
chr4_-_104733580 | 1.87 |
ENSMUST00000064873.9
ENSMUST00000106808.10 ENSMUST00000048947.15 |
C8a
|
complement component 8, alpha polypeptide |
chr3_+_146302832 | 1.87 |
ENSMUST00000029837.14
ENSMUST00000147409.2 ENSMUST00000121133.2 |
Uox
|
urate oxidase |
chr7_+_112806672 | 1.83 |
ENSMUST00000047321.9
ENSMUST00000210074.2 ENSMUST00000210238.2 |
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr5_-_87572060 | 1.83 |
ENSMUST00000072818.6
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr3_+_107137924 | 1.82 |
ENSMUST00000179399.3
|
A630076J17Rik
|
RIKEN cDNA A630076J17 gene |
chr4_+_104623505 | 1.80 |
ENSMUST00000031663.10
ENSMUST00000065072.7 |
C8b
|
complement component 8, beta polypeptide |
chr5_+_90608751 | 1.79 |
ENSMUST00000031314.10
|
Alb
|
albumin |
chr17_+_25097199 | 1.79 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr4_+_34893772 | 1.76 |
ENSMUST00000029975.10
ENSMUST00000135871.8 ENSMUST00000108130.2 |
Cga
|
glycoprotein hormones, alpha subunit |
chr14_-_66246652 | 1.69 |
ENSMUST00000059970.9
|
Gulo
|
gulonolactone (L-) oxidase |
chr15_+_99290763 | 1.69 |
ENSMUST00000023749.15
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr19_+_23118545 | 1.69 |
ENSMUST00000036884.3
|
Klf9
|
Kruppel-like factor 9 |
chr10_-_95678786 | 1.66 |
ENSMUST00000211096.2
|
Gm33543
|
predicted gene, 33543 |
chr19_-_34856853 | 1.65 |
ENSMUST00000036584.13
|
Pank1
|
pantothenate kinase 1 |
chr14_-_31362909 | 1.64 |
ENSMUST00000022437.16
|
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr9_-_45866468 | 1.62 |
ENSMUST00000162072.8
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr18_-_60881679 | 1.61 |
ENSMUST00000237783.2
|
Ndst1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr4_-_19922599 | 1.60 |
ENSMUST00000029900.6
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr9_-_45866264 | 1.59 |
ENSMUST00000114573.9
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr1_+_52158693 | 1.59 |
ENSMUST00000189347.7
|
Stat1
|
signal transducer and activator of transcription 1 |
chr1_-_179373826 | 1.55 |
ENSMUST00000027769.6
|
Tfb2m
|
transcription factor B2, mitochondrial |
chr10_+_87696339 | 1.51 |
ENSMUST00000121161.8
|
Igf1
|
insulin-like growth factor 1 |
chr11_+_118913788 | 1.50 |
ENSMUST00000026662.8
|
Cbx2
|
chromobox 2 |
chr15_+_59520199 | 1.50 |
ENSMUST00000067543.8
|
Trib1
|
tribbles pseudokinase 1 |
chr1_+_52158599 | 1.50 |
ENSMUST00000186574.7
ENSMUST00000070968.14 ENSMUST00000191435.7 ENSMUST00000186857.7 ENSMUST00000188681.7 |
Stat1
|
signal transducer and activator of transcription 1 |
chr3_+_85946145 | 1.49 |
ENSMUST00000238331.2
|
Sh3d19
|
SH3 domain protein D19 |
chr7_-_80052491 | 1.49 |
ENSMUST00000122232.8
|
Furin
|
furin (paired basic amino acid cleaving enzyme) |
chr9_-_44714263 | 1.48 |
ENSMUST00000044694.8
|
Ttc36
|
tetratricopeptide repeat domain 36 |
chr3_+_52175757 | 1.47 |
ENSMUST00000053764.7
|
Foxo1
|
forkhead box O1 |
chr19_-_58443830 | 1.47 |
ENSMUST00000026076.14
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr9_+_47441471 | 1.45 |
ENSMUST00000114548.8
ENSMUST00000152459.8 ENSMUST00000143026.9 ENSMUST00000085909.9 ENSMUST00000114547.8 ENSMUST00000239368.2 ENSMUST00000214542.2 ENSMUST00000034581.4 |
Cadm1
|
cell adhesion molecule 1 |
chr10_-_18110682 | 1.44 |
ENSMUST00000052648.9
ENSMUST00000080860.13 ENSMUST00000173243.8 |
Ccdc28a
|
coiled-coil domain containing 28A |
chr12_-_83643883 | 1.44 |
ENSMUST00000221919.2
|
Zfyve1
|
zinc finger, FYVE domain containing 1 |
chr7_+_100966289 | 1.44 |
ENSMUST00000163799.9
ENSMUST00000164479.9 |
Stard10
|
START domain containing 10 |
chr19_-_58443593 | 1.44 |
ENSMUST00000135730.2
ENSMUST00000152507.8 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr17_-_34846323 | 1.43 |
ENSMUST00000168709.3
ENSMUST00000064953.15 ENSMUST00000170345.8 ENSMUST00000171121.9 ENSMUST00000168391.9 ENSMUST00000169067.9 |
Gm20460
Ppt2
|
predicted gene 20460 palmitoyl-protein thioesterase 2 |
chr1_+_67162176 | 1.43 |
ENSMUST00000027144.8
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr10_+_127734384 | 1.41 |
ENSMUST00000047134.8
|
Sdr9c7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
chr12_-_83643964 | 1.41 |
ENSMUST00000048319.6
|
Zfyve1
|
zinc finger, FYVE domain containing 1 |
chr6_+_134807097 | 1.41 |
ENSMUST00000046303.12
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr1_+_9618173 | 1.39 |
ENSMUST00000144177.8
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1 |
chr11_-_84058292 | 1.39 |
ENSMUST00000050771.8
|
Gm11437
|
predicted gene 11437 |
chr1_+_52158721 | 1.39 |
ENSMUST00000186057.7
|
Stat1
|
signal transducer and activator of transcription 1 |
chr1_+_106099482 | 1.38 |
ENSMUST00000061047.7
|
Phlpp1
|
PH domain and leucine rich repeat protein phosphatase 1 |
chr3_+_20011251 | 1.38 |
ENSMUST00000108328.8
|
Cp
|
ceruloplasmin |
chr3_+_20011201 | 1.36 |
ENSMUST00000091309.12
ENSMUST00000108329.8 ENSMUST00000003714.13 |
Cp
|
ceruloplasmin |
chr10_-_95678748 | 1.34 |
ENSMUST00000210336.2
|
Gm33543
|
predicted gene, 33543 |
chr5_-_147259245 | 1.34 |
ENSMUST00000100433.5
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
chr3_+_90161470 | 1.31 |
ENSMUST00000029545.15
|
Crtc2
|
CREB regulated transcription coactivator 2 |
chr6_-_52617288 | 1.30 |
ENSMUST00000031788.9
|
Hibadh
|
3-hydroxyisobutyrate dehydrogenase |
chr19_+_29078765 | 1.29 |
ENSMUST00000064393.6
ENSMUST00000235900.2 |
Rcl1
|
RNA terminal phosphate cyclase-like 1 |
chr2_+_4722956 | 1.29 |
ENSMUST00000056914.7
|
Bend7
|
BEN domain containing 7 |
chr11_-_100288566 | 1.26 |
ENSMUST00000001592.15
ENSMUST00000107403.2 |
Jup
|
junction plakoglobin |
chr15_-_96947963 | 1.25 |
ENSMUST00000230907.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr1_+_75119472 | 1.25 |
ENSMUST00000189650.7
|
Retreg2
|
reticulophagy regulator family member 2 |
chr9_+_110162470 | 1.24 |
ENSMUST00000198761.5
ENSMUST00000197630.3 |
Scap
|
SREBF chaperone |
chr7_+_127400016 | 1.24 |
ENSMUST00000106271.2
ENSMUST00000138432.2 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr1_+_75119419 | 1.24 |
ENSMUST00000097694.11
ENSMUST00000190240.7 |
Retreg2
|
reticulophagy regulator family member 2 |
chr2_-_64806106 | 1.23 |
ENSMUST00000156765.2
|
Grb14
|
growth factor receptor bound protein 14 |
chr15_-_39720855 | 1.23 |
ENSMUST00000022915.11
ENSMUST00000110306.9 |
Dpys
|
dihydropyrimidinase |
chr6_-_136852792 | 1.23 |
ENSMUST00000032342.3
|
Mgp
|
matrix Gla protein |
chr3_+_20011405 | 1.23 |
ENSMUST00000108325.9
|
Cp
|
ceruloplasmin |
chr4_-_49549489 | 1.21 |
ENSMUST00000029987.10
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr9_+_46139878 | 1.18 |
ENSMUST00000034588.9
ENSMUST00000132155.2 |
Apoa1
|
apolipoprotein A-I |
chr5_+_102629240 | 1.16 |
ENSMUST00000073302.12
ENSMUST00000094559.9 |
Arhgap24
|
Rho GTPase activating protein 24 |
chr10_+_96452860 | 1.16 |
ENSMUST00000038377.9
|
Btg1
|
BTG anti-proliferation factor 1 |
chr3_+_94269745 | 1.14 |
ENSMUST00000169433.3
|
C2cd4d
|
C2 calcium-dependent domain containing 4D |
chr9_-_103107495 | 1.14 |
ENSMUST00000035158.16
|
Trf
|
transferrin |
chr16_+_22710785 | 1.13 |
ENSMUST00000023583.7
ENSMUST00000232098.2 |
Ahsg
|
alpha-2-HS-glycoprotein |
chr17_+_37253802 | 1.13 |
ENSMUST00000040498.12
|
Rnf39
|
ring finger protein 39 |
chr17_+_34250757 | 1.12 |
ENSMUST00000044858.16
ENSMUST00000174299.9 |
Rxrb
|
retinoid X receptor beta |
chr17_+_25059079 | 1.11 |
ENSMUST00000164251.8
|
Hagh
|
hydroxyacyl glutathione hydrolase |
chr19_+_5927821 | 1.11 |
ENSMUST00000145200.8
ENSMUST00000025732.14 ENSMUST00000125114.8 ENSMUST00000155697.8 |
Slc25a45
|
solute carrier family 25, member 45 |
chrX_-_139443926 | 1.11 |
ENSMUST00000055738.12
|
Tsc22d3
|
TSC22 domain family, member 3 |
chr17_-_34846122 | 1.11 |
ENSMUST00000171376.8
ENSMUST00000169287.2 |
Ppt2
|
palmitoyl-protein thioesterase 2 |
chr9_-_103107460 | 1.10 |
ENSMUST00000165296.8
ENSMUST00000112645.8 |
Trf
|
transferrin |
chr19_+_4905158 | 1.09 |
ENSMUST00000119694.3
ENSMUST00000237504.2 ENSMUST00000237011.2 |
Ctsf
|
cathepsin F |
chr19_-_46661321 | 1.09 |
ENSMUST00000026012.8
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr2_+_173579285 | 1.09 |
ENSMUST00000067530.6
|
Vapb
|
vesicle-associated membrane protein, associated protein B and C |
chr9_+_53212871 | 1.07 |
ENSMUST00000051014.2
|
Exph5
|
exophilin 5 |
chr6_-_83633064 | 1.07 |
ENSMUST00000014686.3
|
Clec4f
|
C-type lectin domain family 4, member f |
chr15_-_96918203 | 1.06 |
ENSMUST00000166223.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr10_+_87695886 | 1.05 |
ENSMUST00000062862.13
|
Igf1
|
insulin-like growth factor 1 |
chr11_+_97576619 | 1.05 |
ENSMUST00000107584.8
ENSMUST00000107585.9 |
Cisd3
|
CDGSH iron sulfur domain 3 |
chr7_+_44499005 | 1.05 |
ENSMUST00000150335.2
ENSMUST00000107882.8 |
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chr19_-_46661501 | 1.05 |
ENSMUST00000236174.2
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr19_-_34855278 | 1.03 |
ENSMUST00000112460.3
|
Pank1
|
pantothenate kinase 1 |
chr15_-_5137975 | 1.03 |
ENSMUST00000118365.3
|
Card6
|
caspase recruitment domain family, member 6 |
chr2_+_28531239 | 1.03 |
ENSMUST00000028155.12
ENSMUST00000113869.8 ENSMUST00000113867.9 |
Tsc1
|
TSC complex subunit 1 |
chr7_-_133384449 | 1.03 |
ENSMUST00000063669.8
|
Dhx32
|
DEAH (Asp-Glu-Ala-His) box polypeptide 32 |
chr1_-_184543367 | 1.03 |
ENSMUST00000048462.13
ENSMUST00000110992.9 |
Mtarc1
|
mitochondrial amidoxime reducing component 1 |
chr8_-_64659004 | 1.02 |
ENSMUST00000066166.6
|
Tll1
|
tolloid-like |
chr17_+_34251041 | 1.01 |
ENSMUST00000173354.9
|
Rxrb
|
retinoid X receptor beta |
chr11_-_53313950 | 1.01 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr1_-_162726053 | 1.00 |
ENSMUST00000143123.3
|
Fmo2
|
flavin containing monooxygenase 2 |
chr15_+_59520493 | 1.00 |
ENSMUST00000118228.2
|
Trib1
|
tribbles pseudokinase 1 |
chr12_-_84447702 | 0.99 |
ENSMUST00000122194.8
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5 |
chr8_-_85500010 | 0.99 |
ENSMUST00000109764.8
|
Nfix
|
nuclear factor I/X |
chr2_-_91025492 | 0.98 |
ENSMUST00000111354.2
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chr18_-_32271224 | 0.97 |
ENSMUST00000234657.2
ENSMUST00000234386.2 ENSMUST00000234651.2 |
Proc
|
protein C |
chrX_+_100420873 | 0.97 |
ENSMUST00000052130.14
|
Gjb1
|
gap junction protein, beta 1 |
chr14_+_33662976 | 0.97 |
ENSMUST00000100720.2
|
Gdf2
|
growth differentiation factor 2 |
chr18_+_36797113 | 0.96 |
ENSMUST00000036765.8
|
Eif4ebp3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr2_+_67948057 | 0.96 |
ENSMUST00000112346.3
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr17_-_31363245 | 0.94 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr19_+_34268071 | 0.94 |
ENSMUST00000112472.4
ENSMUST00000235232.2 |
Fas
|
Fas (TNF receptor superfamily member 6) |
chr1_+_131898325 | 0.93 |
ENSMUST00000027695.8
|
Slc45a3
|
solute carrier family 45, member 3 |
chr19_+_31846154 | 0.93 |
ENSMUST00000224564.2
ENSMUST00000224304.2 ENSMUST00000075838.8 ENSMUST00000224400.2 |
A1cf
|
APOBEC1 complementation factor |
chr5_-_45607463 | 0.91 |
ENSMUST00000197946.5
ENSMUST00000127562.3 |
Qdpr
|
quinoid dihydropteridine reductase |
chr19_+_5927876 | 0.91 |
ENSMUST00000235340.2
|
Slc25a45
|
solute carrier family 25, member 45 |
chr6_-_124888643 | 0.91 |
ENSMUST00000032217.2
|
Lag3
|
lymphocyte-activation gene 3 |
chr6_+_79794899 | 0.91 |
ENSMUST00000179797.3
|
Gm20594
|
predicted gene, 20594 |
chr12_-_84447625 | 0.90 |
ENSMUST00000117286.2
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5 |
chr6_+_87405968 | 0.90 |
ENSMUST00000032125.7
|
Bmp10
|
bone morphogenetic protein 10 |
chr19_-_34855242 | 0.90 |
ENSMUST00000238065.2
|
Pank1
|
pantothenate kinase 1 |
chrX_+_7588453 | 0.90 |
ENSMUST00000043045.10
ENSMUST00000207386.2 ENSMUST00000116634.9 ENSMUST00000208072.2 ENSMUST00000207589.2 ENSMUST00000208618.2 ENSMUST00000208443.2 ENSMUST00000207541.2 ENSMUST00000208528.2 ENSMUST00000115689.10 ENSMUST00000131077.9 ENSMUST00000115688.8 ENSMUST00000208156.2 |
Wdr45
Gm45208
|
WD repeat domain 45 predicted gene 45208 |
chr3_+_122277372 | 0.90 |
ENSMUST00000197073.2
|
Bcar3
|
breast cancer anti-estrogen resistance 3 |
chr10_+_116111441 | 0.89 |
ENSMUST00000218553.2
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr15_-_53209513 | 0.89 |
ENSMUST00000077273.9
|
Ext1
|
exostosin glycosyltransferase 1 |
chr7_-_25089522 | 0.89 |
ENSMUST00000054301.14
|
Lipe
|
lipase, hormone sensitive |
chrX_+_7588505 | 0.88 |
ENSMUST00000207675.2
ENSMUST00000116633.9 ENSMUST00000208996.2 ENSMUST00000144148.4 ENSMUST00000125991.9 ENSMUST00000148624.8 |
Wdr45
|
WD repeat domain 45 |
chr4_-_45012093 | 0.87 |
ENSMUST00000131991.2
|
Zbtb5
|
zinc finger and BTB domain containing 5 |
chr11_+_96920956 | 0.87 |
ENSMUST00000153482.2
|
Scrn2
|
secernin 2 |
chr12_-_103923145 | 0.86 |
ENSMUST00000085054.5
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr7_+_44498415 | 0.86 |
ENSMUST00000107885.8
|
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chr13_+_58305455 | 0.86 |
ENSMUST00000226010.2
ENSMUST00000051490.15 ENSMUST00000109868.4 |
Idnk
|
idnK gluconokinase homolog (E. coli) |
chr13_-_53083494 | 0.86 |
ENSMUST00000123599.8
|
Auh
|
AU RNA binding protein/enoyl-coenzyme A hydratase |
chr2_+_24866039 | 0.85 |
ENSMUST00000045295.14
|
Pnpla7
|
patatin-like phospholipase domain containing 7 |
chr19_+_46611826 | 0.85 |
ENSMUST00000111855.5
|
Wbp1l
|
WW domain binding protein 1 like |
chr15_-_96929086 | 0.85 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr5_+_28370687 | 0.85 |
ENSMUST00000036177.9
|
En2
|
engrailed 2 |
chr9_+_44951075 | 0.85 |
ENSMUST00000217097.2
|
Mpzl2
|
myelin protein zero-like 2 |
chr3_-_146302343 | 0.85 |
ENSMUST00000029836.9
|
Dnase2b
|
deoxyribonuclease II beta |
chr11_+_114742619 | 0.84 |
ENSMUST00000053361.12
ENSMUST00000021071.14 ENSMUST00000136785.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr11_-_52173391 | 0.84 |
ENSMUST00000086844.10
|
Tcf7
|
transcription factor 7, T cell specific |
chr19_-_58444336 | 0.83 |
ENSMUST00000131877.2
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chrX_+_93278203 | 0.83 |
ENSMUST00000153900.8
|
Klhl15
|
kelch-like 15 |
chr5_-_87402659 | 0.83 |
ENSMUST00000075858.4
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr13_-_53083674 | 0.82 |
ENSMUST00000120535.8
ENSMUST00000119311.8 ENSMUST00000021913.16 ENSMUST00000110031.4 |
Auh
|
AU RNA binding protein/enoyl-coenzyme A hydratase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 12.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.7 | 6.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.5 | 4.5 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
1.4 | 7.1 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.1 | 1.1 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) |
1.1 | 7.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.0 | 4.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.8 | 2.5 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.8 | 3.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.8 | 4.0 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.8 | 2.3 | GO:0019740 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
0.7 | 4.9 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.6 | 1.9 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.6 | 1.8 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.6 | 3.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 3.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 2.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.4 | 1.2 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.4 | 4.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 9.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 2.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 0.8 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.4 | 1.5 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.4 | 1.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 2.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 8.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.0 | GO:0090650 | rRNA export from nucleus(GO:0006407) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.3 | 1.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 1.0 | GO:1990164 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
0.3 | 2.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 2.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 3.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 0.9 | GO:0031104 | dendrite regeneration(GO:0031104) |
0.3 | 0.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 3.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 2.3 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.3 | 0.8 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 1.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 0.8 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.3 | 1.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 3.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 1.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 1.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.2 | 0.2 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.2 | 3.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 3.9 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.2 | 0.4 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.2 | 0.6 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 1.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.6 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.2 | 1.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 1.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.6 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.2 | 0.6 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.2 | 0.6 | GO:0001966 | thigmotaxis(GO:0001966) |
0.2 | 3.6 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.2 | 3.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 5.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.6 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.2 | 4.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.5 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 1.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 1.5 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 1.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.5 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.6 | GO:0009257 | histidine biosynthetic process(GO:0000105) 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 0.8 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.2 | 0.9 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 3.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.6 | GO:0000239 | pachytene(GO:0000239) RNA 5'-end processing(GO:0000966) |
0.1 | 0.4 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.4 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 3.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 1.5 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.1 | 0.9 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 2.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 3.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 1.7 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 2.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 3.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.7 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 1.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 1.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 4.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 1.0 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 1.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 1.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 1.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.8 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.5 | GO:2000124 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.7 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 12.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.8 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.3 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.1 | 1.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.4 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 2.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.1 | 0.2 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.1 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.3 | GO:0072233 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 10.8 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.2 | GO:0097273 | creatinine homeostasis(GO:0097273) cellular ammonia homeostasis(GO:0097275) cellular creatinine homeostasis(GO:0097276) cellular urea homeostasis(GO:0097277) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 3.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.3 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 1.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.5 | GO:0060762 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) germline stem cell asymmetric division(GO:0098728) |
0.1 | 1.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.3 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 0.3 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 1.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.1 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.7 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 1.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.6 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.0 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 1.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.0 | 0.7 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 2.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 2.6 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.0 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 4.5 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.3 | GO:0031179 | peptide modification(GO:0031179) |
0.0 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 2.5 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 1.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.3 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 2.9 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.3 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.3 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.0 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 4.4 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 1.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 | 0.6 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 2.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 2.5 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
0.0 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.2 | GO:0042594 | response to starvation(GO:0042594) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.8 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.0 | 0.0 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.5 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.7 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 6.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 3.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 2.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 5.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 3.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 9.8 | GO:0042627 | chylomicron(GO:0042627) |
0.4 | 1.9 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 10.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 2.8 | GO:0097433 | dense body(GO:0097433) |
0.3 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.6 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 2.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 3.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 2.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.6 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 1.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 1.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 4.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 2.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 11.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 24.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 5.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 2.0 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) growth cone membrane(GO:0032584) |
0.0 | 1.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 1.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 28.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.3 | 4.0 | GO:0005333 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
1.2 | 8.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 7.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.0 | 4.2 | GO:0005118 | sevenless binding(GO:0005118) |
1.0 | 6.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 5.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.8 | 3.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 4.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 5.5 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 2.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.6 | 3.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 4.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.5 | 3.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 2.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 1.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 4.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 1.4 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.5 | 1.9 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 2.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 3.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.4 | 1.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.4 | 1.2 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.4 | 1.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.4 | 4.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.4 | 2.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 3.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.0 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.3 | 2.2 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 3.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.2 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.3 | 0.9 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.3 | 3.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 2.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 0.8 | GO:0034632 | retinol transporter activity(GO:0034632) |
0.3 | 2.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 3.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.2 | 0.9 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 1.0 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 0.6 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.2 | 1.1 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.2 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 1.0 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 0.6 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.2 | 3.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 1.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.9 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 2.6 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.9 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.4 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 1.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.4 | GO:0071820 | N-box binding(GO:0071820) |
0.1 | 1.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.6 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.1 | 8.9 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 4.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.4 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 3.3 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 5.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 4.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 2.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 2.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 1.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 2.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 3.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.1 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 1.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 4.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.2 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.6 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 2.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 1.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 1.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 1.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 5.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 1.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.3 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.0 | 0.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 1.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.0 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 1.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 9.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 5.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 6.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 8.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 4.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 4.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 2.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 3.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.7 | 5.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 5.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 6.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 4.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 4.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 4.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 3.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 7.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 4.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 5.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 3.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 2.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 3.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 3.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 2.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 2.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 4.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 1.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 5.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 2.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 4.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 7.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.9 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 12.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 3.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 1.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.7 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |